This enactment provides for the development of a national framework to support improved access for Canadians to prevention, diagnosis and treatment of heart failure.
This enactment amends the Canada Business Corporations Act to provide that a corporation’s purpose is to pursue its best interests while also operating in a manner that
(a) benefits the wider society and the environment in a manner proportionate to its size and the nature of its operations; and
(b) minimizes any harm that the corporation causes to the wider society and the environment, with the objective of eliminating such harm.
It also makes related amendments.